{
    "2019-09-25": [
        [
            {
                "time": "2023-10-05",
                "original_text": "How UnitedHealth Group Makes its Money: Premiums, Fees and Health Service Sales",
                "features": {
                    "keywords": [
                        "UnitedHealth",
                        "Premiums",
                        "Fees",
                        "Health Service Sales"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "insurance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "PHOTOS: What brought this primary-care provider for Medicare patients to Charlotte",
                "features": {
                    "keywords": [
                        "primary-care",
                        "Medicare",
                        "Charlotte"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, GlaxoSmithKline, Duke and BlackRock",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst Blog",
                        "Facebook",
                        "UnitedHealth",
                        "GlaxoSmithKline",
                        "Duke",
                        "BlackRock"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "pharmaceuticals",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}